Literature DB >> 19249174

Problem solved: a modified enzyme-linked immunosorbent assay for detection of human antibodies to pertussis toxin eliminates false-positive results occurring at analysis of heat-treated sera.

Tine Dalby1, Maria Seier-Petersen, Max Per Kristiansen, Zitta Barrella Harboe, Karen Angeliki Krogfelt.   

Abstract

Enzyme-linked immunosorbent assay (ELISA) for measurement of antibodies to pertussis toxin (PT) is a widely used method for diagnosis of whooping cough and is also frequently used for seroprevalence studies and for assessment of antibodies after vaccinations against whooping cough. The recommended ELISA procedure for assessment of PT antibodies in human serum does, however, have a serious problem with false-positive results when heat-treated sera are analyzed. Historic sera might have been exposed to routine heat treatment, and diagnostic sera from warm geographic regions are at risk of unintentional exposure to heat. A modified version of the PT ELISA, incorporating a blocking step with 1% milk and addition of 0.1% milk to the dilution buffer, eliminates the false-positive phenomenon occurring with heat-treated sera. Results for serum antibody concentrations correlate well with the currently recommended method. This ELISA modification is straightforward and cheap, and it should be recommended at all analyses incorporating sera with unknown history of heat exposure.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19249174     DOI: 10.1016/j.diagmicrobio.2008.12.004

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  8 in total

1.  Seroprevalence of pertussis among Danish patients with cough of unknown etiology.

Authors:  Tine Dalby; Zitta B Harboe; Karen Angeliki Krogfelt
Journal:  Clin Vaccine Immunol       Date:  2010-10-06

2.  Nonhuman primate model of pertussis.

Authors:  Jason M Warfel; Joel Beren; Vanessa K Kelly; Gloria Lee; Tod J Merkel
Journal:  Infect Immun       Date:  2012-01-17       Impact factor: 3.441

3.  Differences in epitope-specific antibodies to pertussis toxin after infection and acellular vaccinations.

Authors:  Aapo Knuutila; Tine Dalby; Alex-Mikael Barkoff; Charlotte Sværke Jørgensen; Kurt Fuursted; Jussi Mertsola; Kevin Markey; Qiushui He
Journal:  Clin Transl Immunology       Date:  2020-08-02

4.  Pertussis serology: assessment of IgG anti-PT ELISA for replacement of the CHO cell assay.

Authors:  Tine Dalby; Charlotte Sørensen; Jesper Westphal Petersen; Karen Angeliki Krogfelt
Journal:  APMIS       Date:  2010-09-02       Impact factor: 3.205

5.  Epidemiology of pertussis in Denmark, 1995 to 2013.

Authors:  Tine Dalby; Peter Henrik Andersen; Steen Hoffmann
Journal:  Euro Surveill       Date:  2016-09-08

6.  A high seroprevalence of antibodies to pertussis toxin among Japanese adults: Qualitative and quantitative analyses.

Authors:  Takumi Moriuchi; Nao Otsuka; Yukihiro Hiramatsu; Keigo Shibayama; Kazunari Kamachi
Journal:  PLoS One       Date:  2017-07-10       Impact factor: 3.240

7.  Antibody Specificity Following a Recent Bordetella pertussis Infection in Adolescence Is Correlated With the Pertussis Vaccine Received in Childhood.

Authors:  René H M Raeven; Larissa van der Maas; Jeroen L A Pennings; Kurt Fuursted; Charlotte Sværke Jørgensen; Elly van Riet; Bernard Metz; Gideon F A Kersten; Tine Dalby
Journal:  Front Immunol       Date:  2019-06-17       Impact factor: 7.561

8.  Seroepidemiology of pertussis in a cross-sectional study of an adult general population in Denmark.

Authors:  P F Rønn; T Dalby; J Simonsen; C S Jørgensen; A Linneberg; K A Krogfelt
Journal:  Epidemiol Infect       Date:  2013-10-09       Impact factor: 4.434

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.